STAAR Surgical - STAA Book Capitalization

STAA (staar.com) - company brandmark

STAAR Surgical Company (STAA) relies on transparent leadership that effectively penetrates Eastern regions and defends its market positions. R&D activity focused on creating vision correction implants supports its market dominance, and the company's valuation chart reflects the value of 0.36. Production is based on automated lines with computer control, although the implementation of materials and physician training remain human-driven processes.

STAA STAAR Surgical Book Capitalization (07/04/2022 - 10/29/2026)

STAAR Surgical (STAA) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price STAAR Surgical Co|STAA - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization STAAR Surgical Co.|STAA - Total Company Value
- book capitalization data:
Accounting Value per Share STAAR Surgical|STAA - Book Capitalization|Market-to-Book Ratio staar.com|STAA - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio STAAR Surgical Company|STAA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient STAAR Surgical Co.|STAA - Company Aggregate Debts|Debt to Book Value STAAR Surgical Co.|STAA - Company Long-Term Debts|Company Short-Term Debts STAAR Surgical
Fundamental valuation:STAA - STAAR Surgical Co
Mass-produced product of STAAR Surgical Corp

Amidst fierce competition with laser vision correction and ophthalmology behemoths, the net asset value dynamics of STAAR Surgical Company (STAA) demonstrate business resilience. This indicator reflects the company's intrinsic asset value, serving as a guarantee of financial viability. The calculation is performed by subtracting total liabilities from total assets. Growth in this metric confirms the strengthening of the fundamental reserve, characterizing the company as a defensive asset with high baseline reliability.

Competitor analysis for STAAR Surgical Company

ISRG - Book Capitalization|DHR: Book Capitalization|BDX (bd.com) - Book Capitalization|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value ChromaDex Corporation (NAGE)|Company Book Value ZimVie Inc ZIMV|Company Net Assets AngioDynamics Corp|Accounting Value of Company Cerus Inc CERS|Book Capitalization TKNO (Alpha Teknova, Inc.)|MGRM: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)